MENU
+Compare
INBX
Stock ticker: NASDAQ
AS OF
Jul 3 closing price
Price
$15.74
Change
-$0.00 (-0.00%)
Capitalization
236.39M

INBX Inhibrx Biosciences Inc. Forecast, Technical & Fundamental Analysis

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms... Show more

INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for INBX with price predictions
Jul 03, 2025

Aroon Indicator for INBX shows an upward move is likely

INBX's Aroon Indicator triggered a bullish signal on July 03, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 155 similar instances where the Aroon Indicator showed a similar pattern. In of the 155 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 01, 2025. You may want to consider a long position or call options on INBX as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for INBX just turned positive on July 03, 2025. Looking at past instances where INBX's MACD turned positive, the stock continued to rise in of 37 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for INBX crossed bullishly above the 50-day moving average on May 29, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where INBX advanced for three days, in of 277 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INBX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

INBX broke above its upper Bollinger Band on July 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. INBX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.503) is normal, around the industry mean (16.672). P/E Ratio (0.137) is within average values for comparable stocks, (58.456). INBX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.315). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (1250.000) is also within normal values, averaging (269.644).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INBX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

INBX is expected to report earnings to fall 44.64% to -154 cents per share on August 19

Inhibrx Biosciences Inc. INBX Stock Earnings Reports
Q2'25
Est.
$-1.55
Q1'25
Missed
by $1.39
Q4'24
Missed
by $1.65
Q3'24
Missed
by $1.36
Q2'24
Beat
by $127.00
The last earnings report on May 14 showed earnings per share of -279 cents, missing the estimate of -140 cents. With 78.76K shares outstanding, the current market capitalization sits at 236.39M.
A.I. Advisor
published General Information

General Information

a company, which engages in researching and developing biotechnology

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
11025 N. Torrey Pines Road
Phone
+1 858 795-4220
Employees
172
Web
https://www.inhibrx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CGEMY34.290.05
+0.15%
Capgemini SE
GTMAY1.49N/A
N/A
Grupo TMM S.A.B.
VYCO0.13N/A
N/A
Vycor Medical, Inc.
NPEHF17.18N/A
N/A
NIPPON EXPRESS HLDGS INC.
RKAGY7.55-0.04
-0.57%
Rhoen Klinikum AG

INBX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, INBX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if INBX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBX
1D Price
Change %
INBX100%
+3.75%
AXON - INBX
48%
Loosely correlated
+2.70%
AKESF - INBX
45%
Loosely correlated
+11.57%
GBIO - INBX
40%
Loosely correlated
+1.51%
SCPH - INBX
40%
Loosely correlated
-1.73%
SNTI - INBX
39%
Loosely correlated
-0.45%
More